JP2021513507A5 - - Google Patents
Info
- Publication number
- JP2021513507A5 JP2021513507A5 JP2020538823A JP2020538823A JP2021513507A5 JP 2021513507 A5 JP2021513507 A5 JP 2021513507A5 JP 2020538823 A JP2020538823 A JP 2020538823A JP 2020538823 A JP2020538823 A JP 2020538823A JP 2021513507 A5 JP2021513507 A5 JP 2021513507A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- contraceptive
- use according
- coc
- vte
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023168039A JP7651645B2 (ja) | 2018-02-07 | 2023-09-28 | 心臓血管系への影響を低減した避妊薬組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18155571.5 | 2018-02-07 | ||
| EP18155571 | 2018-02-07 | ||
| EP18160586.6 | 2018-03-07 | ||
| EP18160586 | 2018-03-07 | ||
| PCT/EP2019/052980 WO2019154899A1 (en) | 2018-02-07 | 2019-02-07 | Contraceptive composition with reduced cardiovascular effects |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023168039A Division JP7651645B2 (ja) | 2018-02-07 | 2023-09-28 | 心臓血管系への影響を低減した避妊薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021513507A JP2021513507A (ja) | 2021-05-27 |
| JP2021513507A5 true JP2021513507A5 (https=) | 2022-02-15 |
| JPWO2019154899A5 JPWO2019154899A5 (https=) | 2022-02-15 |
Family
ID=65278388
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538823A Pending JP2021513507A (ja) | 2018-02-07 | 2019-02-07 | 心臓血管系への影響を低減した避妊薬組成物 |
| JP2023168039A Active JP7651645B2 (ja) | 2018-02-07 | 2023-09-28 | 心臓血管系への影響を低減した避妊薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023168039A Active JP7651645B2 (ja) | 2018-02-07 | 2023-09-28 | 心臓血管系への影響を低減した避妊薬組成物 |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP4140489A1 (https=) |
| JP (2) | JP2021513507A (https=) |
| KR (1) | KR102717921B1 (https=) |
| CN (2) | CN111683664A (https=) |
| AU (1) | AU2019219070B2 (https=) |
| CA (2) | CA3178181A1 (https=) |
| CL (1) | CL2020002017A1 (https=) |
| EC (1) | ECSP20054822A (https=) |
| GE (2) | GEAP202215414A (https=) |
| IL (1) | IL276584B2 (https=) |
| JO (1) | JOP20200169A1 (https=) |
| MA (1) | MA51733A (https=) |
| NZ (1) | NZ766027A (https=) |
| PH (1) | PH12020500601A1 (https=) |
| PY (1) | PY1908892A (https=) |
| SG (1) | SG11202007163WA (https=) |
| TW (1) | TWI845496B (https=) |
| UA (1) | UA126746C2 (https=) |
| UY (1) | UY38075A (https=) |
| WO (1) | WO2019154899A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116077454A (zh) | 2015-06-18 | 2023-05-09 | 埃斯特拉有限责任公司 | 含雌四醇组分的口腔分散剂量单位 |
| HUE054589T2 (hu) | 2015-06-18 | 2021-09-28 | Estetra Sprl | Szájban diszpergálódó esztetrol tartalmú tabletta |
| RS61777B1 (sr) | 2015-06-18 | 2021-06-30 | Estetra Sprl | Oralno-disperzibilna tableta koja sadrži estetrol |
| MD3310333T2 (ro) | 2015-06-18 | 2020-06-30 | Estetra Sprl | Unitate de dozare orodispersabilă care conține un component estetrol |
| CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| DK3781171T3 (da) | 2018-04-19 | 2022-05-02 | Estetra Srl | Sammensætninger og deres anvendelser til lindring af menopause-associerede symptomer |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| HU231240B1 (hu) | 2019-09-03 | 2022-04-28 | Richter Gedeon Nyrt. | Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására |
| TWI893101B (zh) * | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
| WO2022248733A1 (en) | 2021-05-28 | 2022-12-01 | Neuralis Sa | Use of estetrol in treatment of respiratory infection diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4344405C2 (de) | 1993-12-24 | 1995-12-07 | Marika Dr Med Ehrlich | Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption |
| EP1390042B1 (en) * | 2001-05-23 | 2007-11-28 | Pantarhei Bioscience B.V. | Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception |
| EP1535618A1 (en) * | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions |
| EP2432474A1 (de) * | 2009-05-22 | 2012-03-28 | Bayer Pharma Aktiengesellschaft | Arzneimittel zur oralen verabreichung, enthaltend mindestens ein estrogen und/oder mindestens ein gestagen und mindestens einen probiotischen bakterien-stamm |
| WO2012055840A1 (en) * | 2010-10-28 | 2012-05-03 | Bayer Pharma Aktiengesellschaft | Composition and preparation for treatment of dysmenorrhea and menstrual pain and use of a hormonal agent and a zinc salt for treatment of menstrual disorders |
| NO3079671T3 (https=) * | 2013-12-12 | 2018-03-24 | ||
| CA3178291A1 (en) * | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| KR102780201B1 (ko) | 2016-10-28 | 2025-03-12 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
-
2019
- 2019-02-07 CN CN201980012248.0A patent/CN111683664A/zh active Pending
- 2019-02-07 CA CA3178181A patent/CA3178181A1/en active Pending
- 2019-02-07 EP EP22199066.6A patent/EP4140489A1/en active Pending
- 2019-02-07 KR KR1020207025456A patent/KR102717921B1/ko active Active
- 2019-02-07 NZ NZ766027A patent/NZ766027A/en unknown
- 2019-02-07 EP EP19703103.2A patent/EP3749327A1/en active Pending
- 2019-02-07 IL IL276584A patent/IL276584B2/en unknown
- 2019-02-07 JO JOP/2020/0169A patent/JOP20200169A1/ar unknown
- 2019-02-07 UY UY38075A patent/UY38075A/es not_active Application Discontinuation
- 2019-02-07 AU AU2019219070A patent/AU2019219070B2/en active Active
- 2019-02-07 PY PY201901908892A patent/PY1908892A/es unknown
- 2019-02-07 CN CN202211257175.1A patent/CN115429806A/zh active Pending
- 2019-02-07 MA MA051733A patent/MA51733A/fr unknown
- 2019-02-07 CA CA3089804A patent/CA3089804A1/en active Pending
- 2019-02-07 GE GEAP202215414A patent/GEAP202215414A/en unknown
- 2019-02-07 GE GEAP201915414A patent/GEP20227407B/en unknown
- 2019-02-07 SG SG11202007163WA patent/SG11202007163WA/en unknown
- 2019-02-07 WO PCT/EP2019/052980 patent/WO2019154899A1/en not_active Ceased
- 2019-02-07 JP JP2020538823A patent/JP2021513507A/ja active Pending
- 2019-02-07 UA UAA202005421A patent/UA126746C2/uk unknown
- 2019-02-11 TW TW108104465A patent/TWI845496B/zh active
-
2020
- 2020-07-13 PH PH12020500601A patent/PH12020500601A1/en unknown
- 2020-07-31 CL CL2020002017A patent/CL2020002017A1/es unknown
- 2020-09-04 EC ECSENADI202054822A patent/ECSP20054822A/es unknown
-
2023
- 2023-09-28 JP JP2023168039A patent/JP7651645B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021513507A5 (https=) | ||
| JP7177313B2 (ja) | 避妊用組成物および避妊方法 | |
| Gersema et al. | Use of corticosteroids in oral surgery | |
| KR102780201B1 (ko) | 월경통 및 생리통의 관리방법 | |
| JP7651645B2 (ja) | 心臓血管系への影響を低減した避妊薬組成物 | |
| JP2007512291A (ja) | ２種のエストロゲン及び／又はプロゲスチン組成物を含んで成る、２１〜２８日よりも長い期間にわたっての連続ホルモン処理のための医薬製剤 | |
| JP2019163318A5 (https=) | ||
| RU2022102537A (ru) | Нейроактивные стероиды, их композиции и применения | |
| TW200902030A (en) | Progesterone for the treatment or prevention of spontaneous preterm birth | |
| US20200046729A1 (en) | Methods using combined oral contraceptive compositions with reduced cardiovascular effects | |
| ZA200404249B (en) | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | |
| JPWO2019154899A5 (https=) | ||
| Mircette™ Study Group | An open-label, multicenter, noncomparative safety and efficacy study of Mircette™, a low-dose estrogen-progestin oral contraceptive | |
| TWI351960B (en) | Multiphase product for contraception based on a na | |
| TW200829255A (en) | Use of oestradiol in combination with dienogest for the oral treatment of dysfunctional uterine bleeding in conjunction with oral contraception | |
| EP1462107B1 (en) | Method of female contraception and kit for use in such method | |
| CN101119732A (zh) | 避孕药物制剂 | |
| Adamopoulou et al. | Hormonal Contraception: New Insights on the Risk of Venous Thromboembolism | |
| US20080280861A1 (en) | Method of Female Contraception and a Kit For Use Therein | |
| D'Almeida et al. | Study of who safe abortion regimen in medical abortions in a tertiary centre | |
| Ibrahimi et al. | IMPACT OF ESTROGENS AND PROGESTAGENS ON COAGULATION INHIBITORY PROTEINS AMONG USERS OF COMBINED HORMONAL THERAPY |